Evidence map›Paper›PMID 39272888›Full record

ArticleCancers2024

Traditional Prostate Cancer Risk Assessment Scales Do Not Predict Outcomes from Brain Metastases: A Population-Based Predictive Nomogram.

Liliana R Ladner, Srijan Adhikari, Abhishek S Bhutada, Joshua A Cuoco, Vaibhav M Patel, John J Entwistle, Cara M Rogers, Eric A Marvin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Liliana R LadnerVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA 24016, USA.ORCID 0000-0002-0534-7906
Srijan AdhikariVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA 24016, USA.
Abhishek S BhutadaVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA 24016, USA.
Joshua A CuocoVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA 24016, USA.
Vaibhav M PatelVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA 24016, USA.
John J EntwistleVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA 24016, USA.
Cara M RogersVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA 24016, USA.
Eric A MarvinVirginia Tech Carilion School of Medicine, 2 Riverside Circle, Roanoke, VA 24016, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain metastases are an uncommon yet life-limiting manifestation of prostate cancer. However, there is limited insight into the natural progression, therapeutics, and patient outcomes for prostate cancer once metastasized to the brain. This is a retrospective study of 461 patients with metastatic prostate cancer to the brain with a primary outcome of median overall survival (OS). The Surveillance, Epidemiology, and End Results (SEER) database was examined using Cox regression univariate and multivariable analyses, and a corresponding nomogram was developed. The median overall survival was 15 months. In the multivariable analysis, Hispanic patients had significantly increased OS (median OS 17 months,

Indexed as

brain metastasesnomogramprognosisprostate cancer

Identifiers

PMID39272888
PMCPMC11394481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.